These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32196593)

  • 1. Clinical significance of a new oncogenic factor P5CR1 in gastric cancer.
    Zhang CX; Li Y; Gong WH; Zhang J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2421-2427. PubMed ID: 32196593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P5CR1 protein expression and the effect of gene-silencing on lung adenocarcinoma.
    She Y; Mao A; Li F; Wei X
    PeerJ; 2019; 7():e6934. PubMed ID: 31143549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.
    Xu LP; Qiu HB; Yuan SQ; Chen YM; Zhou ZW; Chen YB
    J Cancer; 2020; 11(9):2708-2715. PubMed ID: 32201541
    [No Abstract]   [Full Text] [Related]  

  • 5. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer.
    Du DX; Lian DB; Amin BH; Yan W
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
    Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer.
    Tang C; Jiang Y; Shao W; Shi W; Gao X; Qin W; Jiang T; Wang F; Feng S
    Int J Oncol; 2016 Oct; 49(4):1489-1496. PubMed ID: 27633497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
    Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
    Shi XY; Sun YZ; Li M; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.
    Liu H; Zhao YR; Chen B; Ge Z; Huang JS
    Cancer Manag Res; 2019; 11():3493-3509. PubMed ID: 31118775
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer.
    Chen LL; He J; Qiu XT; Yu J; Wang ZM
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1063-1068. PubMed ID: 30779073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
    Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway.
    Yan H; Sun Y; Wu Q; Wu Z; Hu M; Sun Y; Liu Y; Ma Z; Liu S; Xiao W; Liu F; Ning Z
    Front Oncol; 2019; 9():1423. PubMed ID: 32117782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.